Alkermes' schizophrenia drug meets main goal of late-stage study
(Reuters) - Alkermes Plc said its experimental drug to treat the symptoms of schizophrenia met the main goal of reducing the severity of symptoms of t...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/_75Po6uWcuo/story01.htm
No comments:
Post a Comment